Post

Conversation

Dr. Catharine Young
@DrCatharineY
Woooooowww. This is the confirmation we’ve been waiting for! Moderna and Merck’s personalized mRNA cancer vaccine reduced the risk of melanoma recurrence or death by 42% when added to Keytruda after surgery, compared with Keytruda alone! And yes, it uses the same mRNA technology behind the COVID vaccines!
Image
56.6K
Views
View quotes
David Watson 🥑
Post your reply

logicwolf
@logicwolf133544
This mRNA vaccine hits residual melanoma cells and downstream tumour mutations and reduces relapse risk. Yet it fails to resolve the upstream root trigger of melanoma. New tumours can form if the root cause remains. This systemic limitation is not individual clinicians’ fault. I
Quote
logicwolf
@logicwolf133544
Article cover image
The Inherent Flaws of TargetedTherapy Drugs
Chronic diseases are not rootcauseless; rather, their root causes have yet to be identified. Every chronic disease originates from its underlying root cause. The drug targets for targetedtherapy...
300
RockyColo
@RockyColo
If there is any silver lining to the COVID pandemic, it’s the fast track approval of mRNA vaccines. The potential applications are limitless.
451
*MeaningfulMinority*
@BringAWarrant
So it was used as an option for a patient who was already sick, which is obviously different than a product being mandatory for a person who is healthy. Surely, You can see the difference?
252
TryKindness
@TryKindnezz
The sad irony here is that the group of people who don’t believe in using sunscreen also won’t take an mRNA vaccine.
75
Square profile picture
Business
@XBusiness
Ad
Launch products now and grow your business with X Ads.
@1x_tech
’s NEO robot campaign shows how X can turn a product announcement into action. As
@Kenny___Rose
put it, X was the perfect launch platform.
The media could not be played.
From x.com
41M
Lui Lulumon
@Luilulumon
First mRNA vax that cause cancer, blood clots, attack itself, have no off switch and gets into your genome... But now mRNA vaccines to combat the same cancers the first one made haha. This will surely work out great and we won't need a 3rd one to fight the cancers from these.
206
Vinny Jay
@VinnyJay87
So neoadjuvant pembro (SWOG1801) and nivo+ipi (NADINA) remains the best approach over a convoluted, wildly expensive (I know we don’t have a price yet but I bet it will be in the CAR-T range), personalized mRNA vaccine.
97